BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 20948306)

  • 1. Reactivation of MASPIN in non-small cell lung carcinoma (NSCLC) cells by artificial transcription factors (ATFs).
    Beltran AS; Blancafort P
    Epigenetics; 2011 Feb; 6(2):224-35. PubMed ID: 20948306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.
    Beltran AS; Sun X; Lizardi PM; Blancafort P
    Mol Cancer Ther; 2008 May; 7(5):1080-90. PubMed ID: 18483297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-activation of a dormant tumor suppressor gene maspin by designed transcription factors.
    Beltran A; Parikh S; Liu Y; Cuevas BD; Johnson GL; Futscher BW; Blancafort P
    Oncogene; 2007 Apr; 26(19):2791-8. PubMed ID: 17057734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of breast tumor growth and metastasis by an engineered transcription factor.
    Beltran AS; Russo A; Lara H; Fan C; Lizardi PM; Blancafort P
    PLoS One; 2011; 6(9):e24595. PubMed ID: 21931769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.
    Villares GJ; Zigler M; Dobroff AS; Wang H; Song R; Melnikova VO; Huang L; Braeuer RR; Bar-Eli M
    Proc Natl Acad Sci U S A; 2011 Jan; 108(2):626-31. PubMed ID: 21187389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting serous epithelial ovarian cancer with designer zinc finger transcription factors.
    Lara H; Wang Y; Beltran AS; Juárez-Moreno K; Yuan X; Kato S; Leisewitz AV; Cuello Fredes M; Licea AF; Connolly DC; Huang L; Blancafort P
    J Biol Chem; 2012 Aug; 287(35):29873-86. PubMed ID: 22782891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.
    Garcia-Bloj B; Moses C; Sgro A; Plani-Lam J; Arooj M; Duffy C; Thiruvengadam S; Sorolla A; Rashwan R; Mancera RL; Leisewitz A; Swift-Scanlan T; Corvalan AH; Blancafort P
    Oncotarget; 2016 Sep; 7(37):60535-60554. PubMed ID: 27528034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maspin expression is transactivated by p63 and is critical for the modulation of lung cancer progression.
    Kim S; Han J; Kim J; Park C
    Cancer Res; 2004 Oct; 64(19):6900-5. PubMed ID: 15466179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural tumor suppressor protein maspin and potential application in non small cell lung cancer.
    Lonardo F; Li X; Kaplun A; Soubani A; Sethi S; Gadgeel S; Sheng S
    Curr Pharm Des; 2010 Jun; 16(16):1877-81. PubMed ID: 20337574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different maspin functions in the lung adenocarcinoma A549 and SPC-A1 cell lines.
    Zhou J; Hualong Q; Zhou P; Guo F
    Int J Mol Med; 2015 Nov; 36(5):1440-8. PubMed ID: 26329803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maspin gene expression is a significant prognostic factor in resected non-small cell lung cancer (NSCLC). Maspin in NSCLC.
    Katakura H; Takenaka K; Nakagawa M; Sonobe M; Adachi M; Ito S; Wada H; Tanaka F
    Lung Cancer; 2006 Mar; 51(3):323-8. PubMed ID: 16406136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene maspin.
    Zhang M; Maass N; Magit D; Sager R
    Cell Growth Differ; 1997 Feb; 8(2):179-86. PubMed ID: 9040939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convergence of p53 and transforming growth factor beta (TGFbeta) signaling on activating expression of the tumor suppressor gene maspin in mammary epithelial cells.
    Wang SE; Narasanna A; Whitell CW; Wu FY; Friedman DB; Arteaga CL
    J Biol Chem; 2007 Feb; 282(8):5661-9. PubMed ID: 17204482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peperomin E reactivates silenced tumor suppressor genes in lung cancer cells by inhibition of DNA methyltransferase.
    Wang XZ; Cheng Y; Wang KL; Liu R; Yang XL; Wen HM; Chai C; Liang JY; Wu H
    Cancer Sci; 2016 Oct; 107(10):1506-1519. PubMed ID: 27501331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The roles of MASPIN expression and subcellular localization in non-small cell lung cancer.
    Wang XF; Liang B; Zeng DX; Lei W; Chen C; Chen YB; Huang JA; Gu N; Zhu YH
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Snail transcription factor negatively regulates maspin tumor suppressor in human prostate cancer cells.
    Neal CL; Henderson V; Smith BN; McKeithen D; Graham T; Vo BT; Odero-Marah VA
    BMC Cancer; 2012 Aug; 12():336. PubMed ID: 22857708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
    Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
    Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic silencing of maspin gene expression in human breast cancers.
    Domann FE; Rice JC; Hendrix MJ; Futscher BW
    Int J Cancer; 2000 Mar; 85(6):805-10. PubMed ID: 10709100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maspin--a novel protease inhibitor with tumor-suppressing activity in breast cancer.
    Maass N; Hojo T; Zhang M; Sager R; Jonat W; Nagasaki K
    Acta Oncol; 2000; 39(8):931-4. PubMed ID: 11206999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.